According to Heska Corporation 's latest financial reports the company's current EPS (TTM) is -ยฃ1.45. In 2022 the company made an earnings per share (EPS) of -ยฃ1.45 a decrease over its 2021 EPS that were of -ยฃ0.07488.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ1.58 | 9.32% |
2022 | -ยฃ1.45 | 1830% |
2021 | -ยฃ0.07488 | -94.19% |
2020 | -ยฃ1.29 | 805.26% |
2019 | -ยฃ0.14 | -123.75% |
2018 | ยฃ0.60 | -43.26% |
2017 | ยฃ1.06 | -9.03% |
2016 | ยฃ1.16 | 93.75% |
2015 | ยฃ0.60 | 81.82% |
2014 | ยฃ0.33 | -309.52% |
2013 | -ยฃ0.16 | -195.45% |
2012 | ยฃ0.16 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | ยฃ8.17 | -665.28% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | ยฃ9.25 | -740.21% | ๐บ๐ธ USA |
![]() Petco WOOF | -ยฃ0.18 | -87.56% | ๐บ๐ธ USA |
![]() Pfizer PFE | ยฃ1.04 | -172.02% | ๐บ๐ธ USA |
![]() Merck MRK | ยฃ5.16 | -457.38% | ๐บ๐ธ USA |
![]() Novartis NVS | ยฃ4.81 | -433.16% | ๐จ๐ญ Switzerland |
![]() Zoetis ZTS | ยฃ4.18 | -389.12% | ๐บ๐ธ USA |